Skip to content

Insider · CIK 0001826084

Ralph Grosswald

officer

Files at DWTX (Dogwood Therapeutics, Inc.). First filing -, latest -.

Ralph Grosswald files SEC Form 4 as officer at DWTX (Dogwood Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Ralph Grosswald has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 5, 2026DWTX
Dogwood Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+82,500$0.00$082,500Mar 6, 2026
Dec 4, 2025DWTX
Dogwood Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+150,000$0.00$0150,000Dec 5, 2025
Jun 27, 2025DWTX
Dogwood Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+12,075$0.00$012,075Jul 1, 2025

Questions about Ralph Grosswald

Answered from the filings on this page, as of the latest one.

Is Ralph Grosswald buying or selling?

Ralph Grosswald has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Ralph Grosswald's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ralph Grosswald has 0.

Where does Ralph Grosswald file Form 4?

Ralph Grosswald has filed Form 4 at DWTX (Dogwood Therapeutics, Inc.) as SVP OF OPERATIONS. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.